Insider Trading History of Eltoukhy Helmy

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Eltoukhy Helmy since 2019. This trader's CIK number is 1752968. At the time of last reporting, Eltoukhy Helmy was the Co-Chief Executive Officer of Guardant Health, Inc.. (stock ticker symbol GH). Also see all insider trading activities at Guardant Health, Inc..



Yearly summary of insider trading at Guardant Health, Inc. (GH) by Eltoukhy Helmy

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 GH 0 $0 0 $0 126,393 $0
2024 GH 0 $0 0 $0 234,384 $836,000
2023 GH 93,052 $2,448,798 0 $0 0 $0
2021 GH 104,500 $10,090,407 1,379,315 $219,424,530 589,115 $99,998
2020 GH 0 $0 900,001 $82,520,566 148,923 $622,496
2019 GH 0 $0 1,406,301 $130,236,951 451,040 $1,885,343


Insider trading of Guardant Health, Inc. (GH) by Eltoukhy Helmy

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-01 GH Option Ex 23,997 .00 0
2025-06-30 GH Option Ex 4,815 .00 0
2025-04-01 GH Option Ex 23,998 .00 0
2025-03-31 GH Option Ex 4,814 .00 0
2025-03-14 GH Option Ex 68,769 .00 0
2024-09-30 GH Option Ex 11,461 .00 0
2024-06-30 GH Option Ex 11,462 .00 0
2024-05-03 GH Option Ex 200,000 4.18 836,000
2024-03-31 GH Option Ex 11,461 .00 0
2023-03-14 GH Buy 84,452 26.33 2,223,874
2023-03-15 GH Buy 8,600 26.15 224,924
2021-11-19 GH Buy 50,000 98.33 4,916,450
2021-11-23 GH Buy 54,500 94.94 5,173,957
2021-08-13 GH Option Ex 23,923 4.18 99,998
2021-04-23 GH Sale 7,388 160.12 1,182,996
2021-04-26 GH Sale 751 160.01 120,166
2021-04-20 GH Sale 16,007 150.25 2,405,051
2021-04-21 GH Sale 56,358 151.03 8,511,974
2021-04-15 GH Sale 157,107 158.78 24,945,292
2021-04-16 GH Sale 51,123 158.35 8,095,429
2021-04-19 GH Sale 50,932 154.03 7,845,106
2021-04-12 GH Sale 72,861 153.97 11,218,335
2021-04-13 GH Sale 105,806 156.14 16,520,866
2021-04-14 GH Sale 60,982 156.33 9,533,072
2021-01-25 GH Sale 58,811 158.13 9,300,018
2021-01-22 GH Sale 102,075 160.84 16,417,538
2021-01-19 GH Sale 103,717 160.08 16,603,432
2021-01-20 GH Sale 212,191 164.34 34,870,407
2021-01-21 GH Sale 173,206 162.06 28,068,898
2021-01-15 GH Sale 150,000 158.57 23,785,950
2021-01-01 GH Option Ex 565,192 .00 0
2020-12-16 GH Option Ex 23,923 4.18 99,998
2020-09-18 GH Option Ex 13,630 4.18 56,973
2020-09-18 GH Sale 65,422 101.91 6,667,417
2020-09-15 GH Option Ex 22,926 4.18 95,830
2020-09-16 GH Option Ex 45,523 4.18 190,286
2020-09-15 GH Sale 110,048 103.58 11,399,101
2020-09-17 GH Option Ex 42,921 4.18 179,409
2020-09-16 GH Sale 218,509 103.91 22,705,051
2020-09-17 GH Sale 206,021 101.01 20,810,181
2020-04-17 GH Sale 15,904 70.71 1,124,587
2020-04-14 GH Sale 2,701 70.06 189,240
2020-04-16 GH Sale 200 70.00 14,001
2020-03-30 GH Sale 178,093 69.09 12,304,801
2020-03-31 GH Sale 103,103 70.86 7,306,187
2019-09-06 GH Option Ex 71,769 4.18 299,994
2019-08-16 GH Sale 166,095 101.08 16,788,882
2019-08-15 GH Sale 26,336 98.55 2,595,333
2019-08-16 GH Option Ex 53,150 4.18 222,166
2019-08-14 GH Sale 61,268 98.23 6,018,416
2019-08-15 GH Option Ex 8,428 4.18 35,229
2019-08-14 GH Option Ex 19,606 4.18 81,953
2019-08-13 GH Sale 307,210 99.24 30,488,442
2019-08-12 GH Sale 119,091 98.97 11,785,840
2019-08-13 GH Option Ex 98,307 4.18 410,923
2019-08-12 GH Option Ex 38,109 4.18 159,295
2019-08-13 GH Sale 307,210 99.24 30,488,442
2019-08-12 GH Sale 119,091 98.97 11,785,840
2019-08-13 GH Option Ex 98,307 4.18 410,923
2019-08-12 GH Option Ex 38,109 4.18 159,295
2019-05-14 GH Option Ex 25,255 4.18 105,565
2019-05-14 GH Sale 78,660 72.26 5,683,971
2019-05-01 GH Sale 41,721 64.63 2,696,511
2019-04-30 GH Sale 89,619 66.18 5,931,254
2019-04-22 GH Sale 90,000 66.38 5,974,020

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eltoukhy Helmy (Co-Chief Executive Officer of Guardant Health, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.